Company news
Nexgenrx Inc. (TSXV:NXG) news
Nexgenrx Inc. news releases on 6ix. Latest, Aug 20, 2026: NexgenRx Announces Second Quarter Results (With Substantial Increases in Revenue, EBITDA…
Press releases & updates
NexgenRx Announces Second Quarter Results (With Substantial Increases in Revenue, EBITDA and Financial Position) and Declaration of Dividend
August 20, 2026
NexgenRx Announces Solid Q1 2026 Results with Continued Increasing Revenue, Net Income and EBITDA Growth
May 21, 2026
Nexgenrx Announces Declaration of Divdend
April 17, 2026
NexgenRx Announces 2025 Year End Results with Continued Increasing Net Income, EBITDA And Revenue Growth
March 31, 2026
NexgenRx Announces Declaration of Divdends
December 10, 2025
NexgenRx Announces Declaration of Dividends
December 10, 2025
NexgenRx Announces Significant Third Quarter Revenue and EBITDA Growth
November 20, 2025
NexgenRx Announces Declaration of Dividend
August 15, 2025
NexgenRx Announces Second Quarter Results with Significant Revenue Growth and Positive EBITDA
August 12, 2025
NexgenRx Announces First Quarter Results With Solid Revenue Growth and Positive EBITDA
May 15, 2025
NexgenRx Announces Declaration of Divdend
April 17, 2025
NexgenRx Announces 2024 Year End Results with Continued Strong Revenue Growth and Increasing Positive EBITDA
April 3, 2025
NexgenRx Announces Third Quarter Results and Declaration of Divdend
November 25, 2024
NexgenRx Announces Director Re-Appointment
October 7, 2024
NexgenRx Announces New Director
October 1, 2024
NexgenRx Announces Second Quarter Results, With Over 19% Revenue Growth and Positive EBITDA
August 15, 2024
NexgenRx Announces Share Issuances Under Consulting Agreement
July 18, 2024
NexgenRx Announces First Quarter Results, with 24% Revenue Growth and Record Earnings
May 17, 2024
NexgenRx Announces Annual Meeting Results
May 16, 2024
NexgenRx Announces 2023 Year End Results With Solid Revenue Growth, Continuing Positive EBITDA
April 5, 2024
NexgenRX Announces Declaration of Dividend
December 20, 2023
NexgenRx Inc. Announces Q3 2023 Quarterly Results with Continued Revenue Growth and Positive EBITDA
November 23, 2023
Nexgenrx Announces Q2 2023 Quarterly Results (With Continued Revenue Growth), Consulting Agreement and Option Grant
August 21, 2023
TSX Venture Exchange Stock Maintenance Bulletins
June 16, 2023
NexgenRx Announces Q1 2023 Quarterly Results with Continued Revenue Growth and Positive EBITDA and Announces Election of New Director
May 18, 2023
NexgenRx Announces 2022 Year End Results With Continued Revenue Growth And Positive EBITDA
April 6, 2023
NexgenRx Announces Q3 2022 Financial Results with Continued Revenue Growth, Positive EBITDA and Free Cash Flow
November 29, 2022
Nexgenrx Announces Declaration Of Dividend
September 23, 2022
NexgenRx Announces Q2 2022 Financial Results with Continued Revenue Growth, Positive EBITDA and Increased Free Cash Flow
August 18, 2022
Nexgenrx Announces Q1 2022 Financial Results with Continued Growth in Net Income, EBIDTA and Revenue
May 17, 2022
NexgenRx Announces 2021 Year End Results with Significant Revenue Growth and $3.5m EBITDA
March 25, 2022
NexgenRx Announces Financial Results for Q3 2021 with Increased Positive EBITDA and Free Cash Flow
November 19, 2021
NexgenRx Announces Expansion of Leadership Team
August 24, 2021
NexgenRx Announces Financial Results for Q2 2021 With Continued Growth in Revenues and Adjusted EBITDA
August 18, 2021
NexgenRx Announces Financial Results for Q1 2021 with Continued EBITDA and Net Profit Growth
May 26, 2021
NexgenRx Announces 2020 Year End Results with Record EBITDA and Net Profit
March 31, 2021
NexgenRx Announces Retirement of all CBA/MYB Outstanding Indebtedness and Stock Option Grants
March 5, 2021
NexgenRx Announces Q3 2020 Results
November 19, 2020
NexgenRx Announces 2020 Q2 Interim Results
August 20, 2020
NexgenRx Announces Amendment of Share Capital, Creation and Issuance of Series 1 Preferred Shares
July 9, 2020
NexgenRx Announces 2020 Q1 Interim Results
May 11, 2020
NexgenRx Announces 2019 Annual Results
April 9, 2020
NexgenRx Announces Q3 2019 Results
November 21, 2019
NexgenRx Announces Debt Re-Structuring
October 11, 2019
NexgenRx Announces Q2 2019 Results
August 16, 2019
NexgenRx Announces Director Retirement
July 5, 2019
NexgenRx Announces Q1 2019 Financials and Annual Meeting Results
May 29, 2019
NexgenRx Announces 2018 Year End Results
April 8, 2019
NexgenRX Announces Option Grants
December 6, 2018
NexgenRx Announces Completion of $425,000 Equity Financing
October 11, 2018